Biocept Salute del bilancio
Salute finanziaria criteri di controllo 2/6
Biocept has a total shareholder equity of $290.0K and total debt of $526.0K, which brings its debt-to-equity ratio to 181.4%. Its total assets and total liabilities are $22.1M and $21.8M respectively.
Informazioni chiave
181.4%
Rapporto debito/patrimonio netto
US$526.00k
Debito
Indice di copertura degli interessi | n/a |
Contanti | US$6.63m |
Patrimonio netto | US$290.00k |
Totale passività | US$21.81m |
Totale attività | US$22.10m |
Aggiornamenti recenti sulla salute finanziaria
Recent updates
Biocept, Inc. (NASDAQ:BIOC) Shares Fly 48% But Investors Aren't Buying For Growth
Apr 17Statutory Earnings May Not Be The Best Way To Understand Biocept's (NASDAQ:BIOC) True Position
Nov 23Just In: One Analyst Has Become A Lot More Bullish On Biocept, Inc.'s (NASDAQ:BIOC) Earnings
Aug 19Shareholders Will Probably Hold Off On Increasing Biocept, Inc.'s (NASDAQ:BIOC) CEO Compensation For The Time Being
Jul 03Biocept and CLEARED4 ink collaboration agreement
Jun 09Biocept enters COVID-19 testing partnership
Apr 28Biocept (NASDAQ:BIOC) Shareholders Have Enjoyed An Impressive 104% Share Price Gain
Mar 13We're Keeping An Eye On Biocept's (NASDAQ:BIOC) Cash Burn Rate
Jan 26Biocept, Inc. (NASDAQ:BIOC): Is Breakeven Near?
Dec 22Biocept's assays viable and sensitive for detecting tumor cells and biomarkers
Nov 20Biocept +4% on COVID-19 testing update
Nov 12Analisi della posizione finanziaria
Passività a breve termine: BIOC's short term assets ($8.9M) exceed its short term liabilities ($4.9M).
Passività a lungo termine: BIOC's short term assets ($8.9M) do not cover its long term liabilities ($16.9M).
Storia e analisi del rapporto debito/patrimonio netto
Livello di debito: BIOC has more cash than its total debt.
Riduzione del debito: BIOC's debt to equity ratio has increased from 20% to 181.4% over the past 5 years.
Bilancio
Analisi della pista di contanti
Per le società che in passato sono state mediamente in perdita, valutiamo se hanno almeno un anno di liquidità.
Pista di liquidità stabile: BIOC has less than a year of cash runway based on its current free cash flow.
Previsione Cash Runway: BIOC has less than a year of cash runway if free cash flow continues to grow at historical rates of 15.3% each year.